Centre for Movement Disorders

North YORK, Ontario M3B 2S7

0 studies enrolling now · 2 studies all time

What they study most

Huntington Disease, Huntingtons Disease

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Intrathecally Administered RO7234292 (RG6042) in Participants With Manifest Huntington's Disease — Completed
• An Open-Label Extension Study to Evaluate Long-Term Safety and Tolerability of RO7234292 (RG6042) in Huntington's Disease Participants Who Participated in Prior Roche and Genentech Sponsored Studies — Completed